SARS-CoV-2: taxonomy, origin and constitution

Authors

DOI:

https://doi.org/10.11606/issn.1679-9836.v99i5p473-479

Keywords:

SARS-CoV-2, Coronavirus, Classification, Viral structure, Origin

Abstract

Introduction: SARS-CoV-2 is a new coronavirus, responsible for the current pandemic of COVID-19, which has already infected and caused the death of thousands of people around the world. Objective: To describe basic and fundamental aspects of SARS-CoV-2, such as its name, constitution, possible origins and classification. Method: Exploratory and descriptive bibliographic review, elaborated through researches on the Pubmed, Scopus, Google Scholar, and Scielo platforms. The terms used for the selection of materials were “SARS-CoV-2” “COVID-19”, “spike-protein”, “classification”, “coronavirus” and their combinations. Results: Coronaviruses belong to the Coronaviridae family, which comprises two subfamilies, five genera, 26 subgenera and 46 virus species. SARS-CoV-2 belongs to the genus Betacoronavirus, subgenus Sarbecovirus, a coronavirus species related to the acute respiratory syndrome. Its classification, carried out by the International Committee on Taxonomy of Viruses (ICTV)], was made in the light of mainly molecular and phylogenetic characteristics and not the actual disease it causes. This virus appeared in China, where people have the habit of consuming recently slaughtered domestic or wild animals. It is speculated that the horseshoe bat (Rhinolophus sinicus) is its primary host and that the Malayan pangolin (Manis javanica) is the secondary host. SARS-CoV-2 is an enveloped virus, approximately spherical and its virions have average diameters of 80-120 nm. It has a non-segmented RNA large size genome which encodes four main proteins spike (S), envelope (E), membrane (M) and nucleoprotein (N). Coronaviruses use S as the main target to neutralize antibodies and to bind to the angiotensin-converting enzyme 2. Conclusion: In-depth knowledge of the basic characteristics of SARS-CoV-2 is essential for better comprehension and understanding of epidemiological aspects, clinical, pathophysiological and treatment of COVID-19.

Downloads

Download data is not yet available.

Author Biographies

  • Omar Arafat Kdudsi Khalil, Instituto Federal de Educação, Ciência e Tecnologia do Paraná (IFPR) Campus Londrina

    Graduação em Farmácia Industrial pela Universidade Federal de Santa Maria (UFSM, 1998); Mestrado em Ciências Farmacêuticas (Faculdade de Ciências Farmacêuticas) pela Universidade Estadual Paulista - Júlio de Mesquita Filho (UNESP, 2002); Doutorado em Biotecnologia pela UNESP, Instituto de Química. Professor universitário ou de ensino técnico há 19 anos (ensino técnico, graduação e pós-graduação); Atualmente, é docente do Instituto Federal de Educação, Ciência e Tecnologia do Paraná (IFPR) Campus Londrina. Atuo com microbiologia, bioquímica, biotecnologia, química, produtos naturais, fármacos. Experiência com os Cursos de Farmácia, Enfermagem, Fisioterapia, Biotecnologia e Licenciatura em Ciências Biológicas

  • Sara da Silva Khalil, Universidade de Brasília (UNB)

    Mestrado pelo Programa de Pós Graduação (PPGEnf) da Universidade de Brasília(UnB). Graduada em Enfermagem: Centro Universitário de Rio Preto - UNIRP (2011). Especialista em Enfermagem do Trabalho: Faculdade de Medicina de São José do Rio Preto - FAMERP (2013). Atuou no/em: - Grupo de Estudos e Pesquisas de Enfermagem em Genômica (GEPEG): USP/EERP Ribeirão Preto-SP (2012). - Prática Profissionalizante: USP/EERP (2012) Assistência de Enfermagem a famílias em risco ou acometidas por Síndromes Neoplásicas Hereditárias. Enfermeira do SAE/DST: Prefeitura Municipal de Andradina-SP (2011-2011). - Enfermeira do Pronto Socorro: Prefeitura Municipal de Palestina-SP (2012-2013). - Coordenadora do SAMU: Prefeitura Municipal de Palestina-SP (2012-2013). - Enfermeira do ESF/PSF: Prefeitura Municipal de Tanabi-SP (2013-2013). - Ministrou aulas teóricas e práticas pelo curso Capacitação de Multiplicadores: Secretaria Municipal de Saúde de São José do Rio Preto-SP (2013-2013).

References

Enquist LW. Virology in the 21st century. J Virol. 2009;83(11):5296-308. doi: https://doi.org/10.1128/JVI.00151-09.

Santos NSO. Novos desafios no ensino da virologia. Rev Pan-Amaz Saude. 2018;9(1):7-8. doi: https://doi.org/10.5123/S2176-62232018000100001.

Chomel BB. Zoonoses. Ref Mod Biomed Sci. 2014. doi: https://doi.org/10.1016/B978-0-12-801238-3.02426-0.

Foster JE. Viruses as pathogens: animal viruses affecting wild and domesticated species. In: Tennant P, Fermin G, Foster J, editors. Viruses. Molecular biology, host interactions, and applications to biotechnology. London: Academic Press; 2018. Chap. 8, p.189-216. doi: https://doi.org/10.1016/B978-0-12-811257-1.00008-5.

Leduc JW, Barry MA. SARS, the first pandemic of the 21st century. Emerging Infect Dis. 2004;10(11):e26. doi: https://doi.org/10.3201/eid1011.040797_02.

World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report – 51. Data as reported by national authorities by 10 AM CET 11 March 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10.

World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report – 82. Data as received by WHO from national authorities by 10:00 CET, 11 April 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200411-sitrep-82-covid-19.pdf?sfvrsn=74a5d15_2.

Gates B. Responding to Covid-19 - a once-in-a-century pandemic? N Engl J Med. 2020;382:1677-9. doi: https://doi.org/10.1056/NEJMp2003762.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. doi: https://doi.org/10.1016/ S0140-6736(20)30183-5.

Fan Y, Zhao K, Shi Z-L, Zhou P. Bat coronaviruses in china. Viruses. 2019;11(210):14. doi: https://doi.org/10.3390/v11030210.

Cheng VCC, Lau SKP, Woo PCY, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20(4):660-94. doi: https://doi.org/10.1128/CMR.00023-07.

Confalonieri UEC. Emergência de doenças infecciosas humanas: processos ecológicos e abordagens preditivas. Oecol Aust. 2010;14(3):591-602. doi: https://doi.org/10.4257/oeco.2010.1403.01.

Kasmi Y, Khataby K, Souiri A, Ennaji MM. Coronaviridae: 100,000 years of emergence and reemergence. In: Ennaji MM, editor. Emerging and reemerging viral pathogens. Vol. I. Fundamental and Basic Virology Aspects of Human, Animal and Plant Pathogens. London: Elsevier Academic Press; 2020. v.1, p.127-49. doi: https://doi.org/10.1016/B978-0-12-819400-3.00007-7.

Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, Sheng J, Quan L, Xia Z, Tan W, Cheng G, Jiang T. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in china. Cell Host Microbe. 2020;27(311):325-8. doi: https://doi.org/10.1016/j.chom.2020.02.001.

Decaro N, Lorusso A. Novel human coronavirus (SARS-CoV-2): a lesson from animal coronaviruses. Vet Microbiol. 2020;244:108693. doi: https://doi.org/10.1016/j.vetmic.2020.108693.

Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181-192. doi: https://doi.org/10.1038/s41579-018-0118-9.

Chan JF-W, Kok K-H, Zhu Z, Chu H, Kai-Wang K, To KK-W, Yuan S, Yuen K-Y. Genomic characterization of the 2019 novel human pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221-36. doi: https://doi.org/10.1080/22221751.2020.1719902.

Han G-Z. Pangolins harbor SARS-CoV-2-related coronaviruses. Trends Microbiol. 2020;28(7):515-7. doi: https://doi.org/10.1016/j.tim.2020.04.001.

Zhang T, Wu Q, Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr Biol. 2020;30(76):1346-51.e2. doi: https://doi.org/10.1016/j.cub.2020.03.022.

Zhou P, Yang XL, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, LI B, Huang C-L, Chen H-D, Chen J, Luo Y, Guo H, Jiang R-D, Liu M-Q, Chen Y, Shen X-R, Wang X, Zheng X-S, Zhao K, Chen Q-J, Deng F, Liu L-L, Yan B, Zhan F-X, Wang Y-Y, Xiao G-F, Shi Z-L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-86. doi: https://doi.org/10.1038/s41586-020-2012-7.

Organização Pan-Americana de Saúde (OPS). COVID-19 (doença causada pelo novo coronavírus). Folha Informativa, 2020. Atual. 17 abr. 2020. Disponível em: https://www.paho.org/bra/index.php?option=com_content&view=article&id=6101:covid19&Itemid=875.

Wang L-F, Anderson DE, Mackenzie JS, Merson MH. From Hendra to Wuhan: what has been learned in responding to emerging zoonotic viroses. Lancet. 2020;395(1022422–28):e33-e34. doi: https://doi.org/10.1016/S0140-6736(20)30350-0.

Gorbalenya AE, Baker SC, Baric RS, De Groot RJ, Drosten C, Gulyaeva AA, Haagmans BL, Lauber C, Leontovich AM, Neuman BW, Penzar D, Perlman S, Poon LLM, Samborskiy DV, Sidorov IA, Sola I, Ziebuhr J. The species severe acute respiratory syndrome related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. Nat Microbiol. 2020;5(536):536-44. doi: https://doi.org/10.1038/s41564-020-0695-z.

Jiang S, Shi Z, Shu Y, Song J, Gao GF, Tan W, Guo D. A distinct name is needed for the new coronavirus. Lancet. 2020;395(1022821-27):949. doi: https://doi.org/10.1016/S0140-6736(20)30419-0.

Jiang S, Hillyer C, Du L. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol. 2020;41(5):355-359. doi: https://doi.org/10.1016/j.it.2020.03.007.

World Health Organization (WHO). Naming the coronavirus disease (COVID-19) and the virus that causes it. Geneve; 2020 [cited 2020 April 12]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.

World Health Organization (WHO). Novel coronavirus (2019-nCoV) situation report – 22. Geneve; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf.

Calisher CH. Qual é a diferença entre uma espécie de vírus e um vírus? A mesma diferença existente entre Homo sapiens e você. Rev Pan-Amaz Saude. 2010;1(3):137-9. doi: https://doi.org/10.5123/S2176-62232010000300019.

International Committee on Taxonomy of Viruses (ICTV). Virus taxonomy: 2018b release. EC 50, Washington, DC; July 2018. Email ratification February 2019 (MSL #34). Available from: https://talk.ictvonline.org/taxonomy/.

Ko W-C, Rolain J-M, Lee N-Y, Chen P-L, Huang CT, Lee P-I, Hsueh P-R. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents. 2020;55(4):article 105933. doi: https://doi.org/10.1016/j.ijantimicag.2020.105933.

Woo PC, Lau SKP, Lam CSF, Lau Ccy, Tsang AKL, Lau JHN, Bai R, Teng JLL, Tsang CCC, Wang M, Zheng, B-J, Chan K-H, Yuena K-Y. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol. 2012;86(7):3995-4008. doi: https://doi.org/10.1128/JVI.06540-11.

Jaimes JA, André NM, Chappie JS, Millet JK, Whittaker GR. Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop. J Mol Biol. 2020;432(10):3309-25. doi: https://doi.org/10.1016/j.jmb.2020.04.009.

Masters PS. The molecular biology of coronaviruses. Adv Virus Res. 2006;66:193-292. doi: https://doi.org/10.1016/S0065-3527(06)66005-3.

Fung S, Liu DX. Human coronavirus: host-pathogen interaction. Annu Rev Microbiol. 2019;73:529-57. doi: https://doi.org/10.1146/annurev-micro-020518-115759.

Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z, Mu Z, Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11(1620):1-12. doi: https://doi.org/10.1038/s41467-020-15562-9.

Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochem Biophys Res Commun. 2020;526(121):165-9. doi: https://doi.org/10.1016/j.bbrc.2020.03.047.

Fuzimoto AD, Isidoro C. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds – Additional weapons in the fight against the COVID-19 pandemic? J Tradit Complement Med. 2020;10(40):405-19. doi: https://doi.org/10.1016/j.jtcme.2020.05.003.

Koirala, A, Joo JY, Khatami A, Chiu C, Britton, PN. Vaccines for COVID-19: the current state of play. Paediatr Respir Rev. 2020;35:43-9. doi: https://doi.org/101016/j.prrv.2020.06.010.

Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, Ganesan S, Venugopal A, Venkatesan D, Ganesan H, Rajagopalan K, Rahman PKSM, CHO S-G, Kumar NS, Subramaniamk MD. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138227. doi: https://doi.org/10.1016/j.scitotenv.2020.138277.

Published

2020-12-10

Issue

Section

Artigos de Revisão/Review Articles

How to Cite

Khalil, O. A. K., & Khalil, S. da S. (2020). SARS-CoV-2: taxonomy, origin and constitution. Revista De Medicina, 99(5), 473-479. https://doi.org/10.11606/issn.1679-9836.v99i5p473-479